Introduction
There are currently few guidelines to assist pain medicine physicians in determining the best safety practices to follow when performing interventional pain procedures. Recent guidelines advocated by the American Society of Regional Anesthesia (ASRA) address anticoagulation. 1 The American Society of Anesthesiologists (ASA) suggested in 2010 that minor pain procedures, under most routine circumstances, do not require
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Kohan et al anesthesia care other than local anesthesia. 2 We found little information regarding recommendations for restrictions on oral intake prior to interventional pain procedures, cumulative steroid dose limits and timing of dosing, driving restrictions with and without sedation, or routine medication use prior to interventional procedures. The recent ASRA guidelines address nonsteroidal anti-inflammatory drugs (NSAIDs), as well as garlic, gon quai, danshen, ginkgo bilboa, and panaz ginseng. We attempted to statistically analyze the practices, which were reported by pain medicine physicians, and to determine if there was any uniformity in such safety policies or commonly accepted standards specifically related to interventional pain procedures. Also included in the survey was the rate at which steroids are being utilized in various interventional pain procedures and how often policies addressed limiting the frequency of dose or intervals between doses.
Methods
A 16-question survey was developed on common practices currently in use before an interventional pain procedure (Supplementary material). The questions addressed NPO status, cessation of anticoagulants, use of sedation, and the driver policy for sedated patients versus nonsedated patients. Corticosteroid use among the most common interventional pain procedures was assessed using the time intervals between repeated doses. The survey was hosted on the Internet through SurveyMonkey™. The questionnaire was dispersed through the following two professional organizations that agreed to assist with this study by forwarding the SurveyMonkey™ link to their membership: ASRA and Pain Medicine and American Academy of Pain Medicine. This survey was dispersed to all the members of the above organizations. The survey was open 212 days, and no compensation was given for completing the survey. Since this survey did not involve any identifiable patient information or a clinical investigation, consent was implied with a voluntary return of the completed survey. The results were analyzed and are reported in simple descriptive statistics.
Results
A total of 337 physicians responded to the survey. Results from 41 respondents were not included because they did not complete the entire survey questionnaire.
Use of sedation
A total of 82% of respondents used a sedative agent while performing an interventional pain procedure. The use of sedation depended on the type of procedure being performed. Sedation was used in 80% of the patients for radiofrequency ablation procedures, 66% of the patients for sympathetic blocks, 54% of the patients for epidural steroid procedures, 50% of the patients for medial branch nerve blocks, 43% of the patients for regional nerve blocks (ilioinguinal/ iliohypogastric, femoral, supraclavicular, and so on), 42% of the patients for sacroiliac joint injections, 30% of the patients for superficial peripheral blocks (occipital, supraorbital, and so on), 20% of the patients for intraarticular nerve blocks, and 5% of the patients for trigger point injections.
The most commonly used class of drugs for sedation was benzodiazepines, reported by 97% of the participants. Opioids were administered by 77% of the respondents, N-methyl-d-aspartate (NMDA) receptor antagonists were administered by 15% of the respondents, antihistamines were administered by 7% of the respondents, and alpha-2 agonists were administered by 7% of the respondents. Of note, propofol was used by 36% of the respondents. Linkage between specific procedures and sedatives was not sought in an effort to limit the duration of the survey.
Driver policy
The majority of respondents required drivers after procedures, except after trigger points. Procedures involving local anesthetic were more likely to require a designated driver. However, not all respondents required drivers even if the procedure could be associated with risks such as sympathectomy and motor blockade. The addition of sedation consistently increased the requirement of a designated driver, yet this was still not 100%. The differences on driver policy based on the type of procedure without and with the use of sedation are listed in Tables 1 and 2 , respectively.
Policies regarding timing of corticosteroid doses
Participants were asked if there was a minimal time interval between the administrations of corticosteroids. A total of 82% indicated that there was a time interval. A total of 17% indicated that the interval was <2 weeks, while 53% indicated that they waited 2-4 weeks between steroid doses. A total of 30% of the physicians also indicated waiting more than a month between two successive exposures. Steroid use for different procedures is reported in Table 3 .
Aspirin or other antiplatelet medications
Wide variations were seen in the length of time patients were asked to hold their antiplatelet medication or aspirin before an interventional pain procedure. A total of 67% respondents 
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A review of policies utilized for interventional pain procedures did not have a policy to hold aspirin before an interventional pain procedure. The length of time that aspirin was held in relation to procedures is listed in Table 4 .
A total of 70% of the physicians in the survey reported that they did not ask patients to hold their NSAIDs prior to an injection. Among those who did ask patients to hold NSAIDs, the length of time that the NSAIDs were held depended on the type of procedure being performed (Table 5 ).
Anticoagulants
Highest consensus was found in regard to anticoagulants, such as heparin, enoxaparin, and warfarin. A total of 98% of the respondents indicated that they asked their patients to stop these anticoagulants before an interventional pain procedure.
Medications, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and herbal medications, were not held by 73% of the respondents. For those who did hold SNRIs and SSRIs, specifics were not sought regarding procedures or duration of that hold.
Nil per os (NPO) policy
A total of 47% of the physicians indicated that they have an NPO policy in procedures without sedation. In patients receiving sedation for procedures, a majority (90%) indicated that they have a policy.
IRB approval
IRB approval is not needed. This study was determined to not meet the criteria of research with human subjects or a clinical investigation and, therefore, is not subject to Institutional Review Board for Health Sciences Research (IRB-HSR) review (University of Virginia's IRB-HSR tracking number with IRB exempt status -19622).
Discussion
Currently, few best practice guidelines exist to assist interventional pain physicians with periprocedural care. While anesthesiology has established guidelines for monitoring the anesthesia care, these guidelines have not been embraced by the multidisciplinary pain medicine community. 3 Our survey found that there is a wide variation in the safety policies related to oral intake, designated drivers, use of sedation, and medication use that are used by the responding physicians providing interventional pain care. This variation may potentially be due to the lack of established guidelines specifically for interventional pain procedures, 
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Kohan et al or the simplicity of implementing a single policy for all drugs (eg, holding all medications that could affect coagulation for 1 week, even when the half-life is 6 hours), or all procedures (eg, NPO). Lack of consistency could also reflect the range of training options for interventional pain, where some specialties may be more attuned to particular safety issues than others.
NPO policies
There are currently no established guidelines addressing NPO policies in patients receiving interventional pain procedures. Kennedy et al 4 in 2013 examined >4000 subjects and found the incidence of vasovagal episodes to be 2.6% with a range of 0% in peripheral knee and shoulder injections to 5.1% in medial branch blocks. Significant bradycardia and hypotension are possible under these circumstances, including loss of consciousness. This scenario raises concerns for the risk of aspiration. Inadvertent subarachnoid local anesthetic during an epidural carries the risk of total loss of spinal and airway reflexes, again bringing into question the need for NPO guidelines. Similarly, procedures, such as stellate ganglion blocks and C2 medial branch nerve blocks, can be associated with intravascular injection and seizures with even very small volumes of local anesthetic. The presence of a full stomach under any of these circumstances could have catastrophic results. While >90% of the respondents indicated that they have an NPO policy for patients undergoing procedures with sedation, the apparent lack of perceived risk in procedures without sedation is concerning.
Sedation
Our study demonstrated that variation exists in the use of sedation during various interventional pain procedures. The emphasis on patients' satisfaction in today's medical climate may fuel the use of sedation during these procedures, despite known risks, although in 2010, the American Society of Anesthesiology clearly stated that the majority of minor pain procedures, under most routine circumstances, do not require anesthesia care other than local anesthesia. 5 The procedures that were specified include epidural steroid injections, trigger point injections (TPIs), epidural blood patches, sacroiliac joint injections, bursa injections, occipital nerve blocks, and facet injections. Studies have demonstrated an increased risk of neurological injury when patients received moderate or heavy sedation, and furthermore, the risk of spinal cord injury during cervical procedures has been shown to be higher in patients who received sedation and local or general anesthesia. 6, 7 Patients who are sedated may not be able to report pain or paresthesias in case of inadvertent spinal nerve or cord contact, thus significantly increasing the risk of injury. 8 Despite these findings, 36% of the physicians in our survey used propofol when performing interventional spine procedures. Finally, administration of analgesics prior to diagnostic blocks (eg, medial branch nerve blocks) raises concerns about the validity of the results. It may be difficult to determine if the relief was due to the block or the opioid. 9 Studies have also demonstrated lack of significant improvement in patient satisfaction when receiving sedation. In a retrospective audit, Diehn et al 10 
demonstrated that
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A review of policies utilized for interventional pain procedures the majority of nonsedated patients rated their care as good (15%), very good (30%), or excellent (51%), thus implying that high patient satisfaction rates can be achieved without the use of sedation. In addition, the authors stated that the rate of vasovagal reactions was low (0.4%) in nonsedated patients.
Other studies have confirmed similar low rates of vasovagal episodes in nonsedated patients undergoing epidurals. 11 Furthermore, Cohen et al assessed the effect of sedation on the accuracy of diagnostic injections and patient satisfaction in a randomized, controlled, crossover study. They found that the use of sedation in diagnostic sacroiliac joint or sympathetic nerve blocks resulted in lower pain diary scores than those performed without sedation potentially increasing the risk of false-positive blocks. In contrast, they did not find differences in patient satisfaction between the sedation and nonsedation groups. 12 Cucuzzella et al 13 performed a survey of 500 patients who had received cervical, thoracic, lumbar, epidural, or facet injections and found that only 17% had requested sedation before the procedure if given a choice. In a follow-up study, Cucuzzella's group found that while slightly more than half of patients chose sedation, 93% of those who did not choose sedation were satisfied with their decision, while only 1.5% of them had wished that they had chosen sedation.
14 Use of analgesic sedation for diagnostic medial branch nerve blocks could contribute to decreased pain post procedure, confounding the diagnostic value, and potentially increase the rate of subsequent unnecessary denervation procedures.
No systematic studies have been performed to establish relationships between various levels of sedation given for different interventional pain procedures and driving accidents after such procedures. Data do exist regarding fall risks, driving risks, and aspiration risks after various types of anesthesia for surgical procedures; however, whether the data are directly applicable to pain medicine interventions is a matter at least worth discussion.
It is clear from our survey that there is no consensus about the risk/benefit ratio associated with sedation for interventional pain procedures. This is reflected by the wide variation in the use of sedation in almost all the pain procedures mentioned. For example, 50% of the respondents used sedative agent in medial branch block. This may reflect an underappreciation of the risks, a lack of concern regarding the impact of sedation on the efficacy of diagnostic blocks, and/or the pressure to have high patient satisfaction scores. Hence, further study regarding the risks, benefits, and efficacy of sedation during interventional pain procedures in order to establish recommendations for appropriate, evidence-based best practices is critical.
Driver policy
There are no current guidelines for driver policy to help physicians practice evidence-based care. In our survey, a vast majority of physicians agreed on having a driver policy for procedures involving sedation. The response to procedures that were not done under sedation was varied, with as many as 40% physicians not requiring a driver after a procedure without sedation. These policies did not appear to differentiate between procedures that could be associated with hypotension or motor blockade in any meaningful fashion. The only procedure that stood out was trigger point injections, with the minority of respondents requiring a designated driver. While having a designated driver is often inconvenient to the patient and the driver and can be expensive due to lost work or accrued childcare expense, all procedures we surveyed carry risks that could incapacitate a patient. While there is no guideline regarding designated drivers for pain procedures, anesthesia guidelines for monitored anesthesia exist. Policies exist for other procedures involving sedation including colonoscopy. 15 Having a driver policy is of utmost importance as certain pain procedures such as epidural steroid injection with local anesthetic and sacroiliac joint injections in patients with congenital sacral nonunions can cause inadvertent numbness and weakness in the leg, which obviously interferes with the ability to ambulate and drive safely. Sedation puts the patient at risk of driving under the influence, depending on the drugs used, and the time after administration to discharge. The wide variation in protocol, and the attendant risks associated with a lack of clear guidelines, raises concerns of patient safety as well as potential provider liability and medicolegal issues. This lack of consensus on various policies regarding periprocedural care is potentially dangerous and can lead to adverse events. This also reflects the varied perception of risk related to various components of procedural care. Until guidelines specific to the outpatient pain population are available, adherence to the anesthesia guidelines likely offers the safest, most defensible practice. 15 
Steroids
This survey also examined practices related to the frequency of use of corticosteroids in interventional pain procedures. Corticosteroids can be associated with numerous potential risks. Such side effects include weight gain, osteoporosis, hypertension, hyperglycemia, and adrenal suppression. A recent study by Goel et al 16 suggests that 45% of the chronic pain patients who were being considered for a steroid injection as part of their treatment plan screened positive for the risk of adrenal suppression due to previous corticosteroid exposure from many sources including various injections, oral and inhaled steroids, and topical application prior to undergoing interventional pain procedures. Other studies have shown evidence of adrenal suppression with symptoms, such as low blood pressure, fatigue, and weight loss, following a single epidural steroid injection. Huebner et al 17 showed depressed plasma cortisol levels even after 1-2 weeks after an epidural steroid injection. Jacobs et al 18 found evidence of adrenal suppression at 3 weeks after a single epidural steroid injection. Prolonged suppression of adrenal function has also been found in healthy volunteers after intraarticular steroid injections. 19 It is promising that most respondents (83%) indicated that they wait at least ≥2 weeks before reinjecting with steroid. However, 17% of the respondents waited <2 weeks before reinjecting with steroid. This practice may potentially place patients at risk for adrenal suppression as well as overt iatrogenic Cushing's syndrome, particularly with repeated injections. In addition, 42% of the respondents indicated they have often used steroids for TPIs, while a third of the responders used it for MBBs. This is in spite of the fact that there is no data to support the efficacy of corticosteroids for intramuscular injections and the theoretical risk of muscle atrophy. 20 This routine use of steroids for these types of procedures may further place patients at unnecessary risk of adrenal suppression. It is clear that there is need for more research and the development of guidelines over the repeated use of steroids and the over utilization of steroids in procedures where they add limited benefit.
Anticoagulants
Finally, the survey also examined the length of time that anticoagulants were held prior to various pain procedures. Our survey demonstrated a variation in response to the amount of times that aspirin and NSAIDs were held prior to various procedures. The study was conducted prior to the recent release of the ASRA guidelines regarding the use of anticoagulants in pain procedures. 1 It will be interesting to see if the recently published 2015 ASRA guidelines regarding neuroaxial blockade and regional nerve blocks will lead to a change in practice policies regarding anticoagulation. 21 It is very possible that the preexisting anticoagulation guidelines from ASRA contributed to the almost universal positive response to the anticoagulation questions.
Limitations
This survey had some limitations. In an effort to limit the length of the survey and, hence, improve the response rate, specialty, or training of provider, the type of practice was not asked or linked to the use of sedation, NPO status, driving restrictions, or steroid utilization. Participants were not asked about which specific type of NSAIDs was held before a procedure. Discontinuation of anticoagulants was asked in regard to all procedures and was not asked in relation to a particular procedure. It would have been helpful to determine if actual dose of steroid administered influenced the number and timing of injections, as well. Length of NPO policy and relation to individual types of procedures were not asked.
Conclusion
Currently, there are few published guidelines to assist interventional pain physicians in their practice. While the number of responses to the survey is limited and may not be applicable to all pain medicine interventional practices, we did identify a wide variation in the current practice among physicians regarding sedation, NPO status, steroid administration, management of other medications that could impact coagulation such as NSAIDs, herbal medications, and SSRIs, and the need for designated drivers. Establishment of a reporting database for adverse outcomes would assist in identifying the actual risk of these various practices. There is an obvious need for evidence-based best practice guidelines for these aspects of interventional pain care to improve patient safety and minimize the risk of adverse events.
